GENETIC IMMUNITY INC
Genetic Immunity is a US/Hungarian clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of immunotherapeutic biologics ("Immune Therapies" or "Therapeutic Vaccines") for the treatment of chronic viral infections, cancer and allergies. Our Immune Therapies are designed to intensify or boost specific immune responses to modify or control these presently incurable diseases. We believe that our products will allow people to live a better, h... ealthier and longer life. Our proprietary Immunetherapy Platform Technology includes a plasmid DNA-based antigen, a nanomedicine formulation and a topical administration device that targets antigens to dendritic cells. Our technologies support the rapid and cost-effective development of original biologic products for several indications and provides tools for the selection of an optimal treatment regime for patients, based on his or her disease and genetic background. Our Lead Product Candidate for the treatment of HIV/AIDS, called "DermaVir", is a therapeutic HIV vaccine effective in boosting immune responses that kill HIV-infected cells. Our preclinical, Phase I, Phase I/II and Phase II clinical trials have demonstrated boosting of HIV-specific T cells and specific killing of HIV-infected cells that are not eliminated by current antiretroviral drugs. DermaVir has an excellent safety profile similar to vaccines used in healthy adults and children. The goal of DermaVir immune intensification is to modify HIV disease, decrease antiretroviral drug exposure while maintaining undetectable HIV-RNA levels, thereby achieving a remission (functional cure) in HIV-infected patients. We also have an extensive pipeline of product candidates, a number of which have animal proof of concept, for example, for the treatment of Chlamydia, called "ChlamyDerm" and our allergen-specific immunotherapy, called "DermAll". ChlamyDerm has successfully decreased the amount of infected cells together with infection-associated inflammation in mice experiments. DermAll decreased the allergic symptoms by balancing allergen-specific immune responses in mice experiments. Our other pipeline candidates for virus-associated cancers and warts are in discovery phase. Genetic Immunity is a wholly owned subsidiary of Power of the Dream ventures, Inc.
GENETIC IMMUNITY INC
Social Links:
Industry:
Pharmaceutical
Founded:
1998-01-01
Website Url:
http://www.geneticimmunity.com
Total Employee:
1+
Status:
Active
Contact:
(361)456-6061
Email Addresses:
[email protected]
Technology used in webpage:
SPF Font Awesome Nginx Google Maps API COVID-19 CPanel SSL StatCounter
Current Advisors List
Official Site Inspections
http://www.geneticimmunity.com Semrush global rank: 5.89 M Semrush visits lastest month: 1.4 K
- Host name: vps1.onoffice.hu
- IP address: 213.16.88.71
- Location: Zalaegerszeg Hungary
- Latitude: 46.8409
- Longitude: 16.8399
- Timezone: Europe/Budapest
- Postal: 8900
More informations about "Genetic Immunity Inc"
Genetic Immunity Inc - Crunchbase Company Profile
Genetic Immunity Inc is a company that manufactures vaccines. Genetic Immunity is a US/Hungarian clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of โฆSee details»
Genetic Immunity
GI.HU Ltd, the Hungarian subsidiary of Genetic Immunity, Inc., has been granted the rights to therapeutic vaccine research, development, and production. Our company has developed its โฆSee details»
Genetic Immunity - Overview, News & Competitors | ZoomInfo.com
Genetic Immunity's lead product candidate for the treatment of HIV has completed three clinical trials to date with well-established immune-boosting properties. Read More. View Company โฆSee details»
Genetic Immunity Company Profile | Management and Employees โฆ
Genetic Immunity Profile and History. Genetic Immunity is a development stage biotechnology company focusing on therapeutic vaccine research. The company's proprietary platform โฆSee details»
Genetic Immunity®๏ธ - LinkedIn
GI.HU Ltd (Genetic Immunity®๏ธ) is developing a DNA, transdermal immunotherapy platform to treat viral and cancer diseases. Our product candidate, DermaVir®๏ธ DNA HIV Therapeutic Vaccine, is a ...See details»
Genetic Immunity Inc - Company Profile and News
Genetic Immunity, Inc. offers technology services to create and design pharmaceuticals. The Company discovers, develops, and manufactures biologic drugs for viral infections, cancer, โฆSee details»
Genetic Immunity - VentureRadar
Genetic Immunity is a US clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of pDNA based immunotherapies โฆSee details»
Genetic Immunity, Inc. - Drug pipelines, Patents, Clinical trials
Explore Genetic Immunity, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 3 literature, Disease Domain:Immune System ...See details»
Genetic Immunity - PitchBook
Genetic Immunity General Information Description. Manufacturer of transdermal immunotherapy drugs intended to treat chronic viral infections, cancer and allergies. The company's drugs are designed to intensify or boost T-cell โฆSee details»
Interview with Julianna Lisziewicz, President, Genetic Immunity
Oct 31, 2011 In the beginning, Genetic Immunity was therefore more of a virtual company. In the beginning of 2004, when we started the clinical development, we understood that this was an โฆSee details»
Genetic Immunity Inc - Contacts, Employees, Board Members
Organization. Genetic Immunity Inc . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Genetic Immunity Inc has 2 โฆSee details»
The dynamic interface of genetics and immunity: toward future โฆ
Jul 18, 2023 The multidisciplinary research field at the interface of immunology and genetics is currently experiencing an unprecedented expansion and tremendous progress.See details»
A global effort to dissect the human genetic basis of ... - Nature
Oct 18, 2021 SARS-CoV-2 infections display tremendous interindividual variability, ranging from asymptomatic infections to life-threatening disease. Inborn errors of, and autoantibodies โฆSee details»
From evolutionary genetics to human immunology: how selection โฆ
Dec 1, 2009 The recent increase in available human population genetic data is revealing signatures of selection at immunity-related genes. This Review discusses how studies of โฆSee details»
Chapter 12. Genetics of Immunity โ Human Genetics
According to the World Health Organization (WHO), as of May 2023 one tenth of the planetโs population contracted COVID-19 and there have been nearly 7 million deaths from COVID-19 โฆSee details»
Evolutionary and Population (Epi)Genetics of Immunity to Infection
Introduction. Over the last decade, it has become increasingly clear that understanding the different ways in which natural selection can act informs the biological relevance of immune โฆSee details»
Trained Innate Immunity, Epigenetics, and Covid-19
Sep 9, 2020 The relative importance of imprinting of myeloid-cell function in hematopoietic stem cells, as described by de Laval et al., as compared with that of mature macrophages, 1 โฆSee details»
Human immune diversity: from evolution to modernity
Nov 18, 2021 The extreme diversity of the human immune system, forged and maintained throughout evolutionary history, provides a potent defense against opportunistic pathogens. โฆSee details»
Impact of Genetic Polymorphisms on Human Immune Cell Gene โฆ
Nov 29, 2018 The Genotype-Tissue Expression (GTEx) consortium assessed the association of genetic variants with gene expression levels (expression quantitative trait loci or eQTLs) โฆSee details»